Applications of Bioassay for Radioiodine, 54752-54753 [2014-21757]

Download as PDF 54752 Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices APPENDIX A—IN THE MATTER OF JAMES CHAISSON: DEADLINES SPECIFIED IN INITIAL SCHEDULING ORDER—Continued Deadline Action ISO section Mid to late March 2015 * ............................ Evidentiary hearing ....................................................................................................... ISO IV.E * These dates are subject to change and will be discussed during the second prehearing conference. [FR Doc. 2014–21827 Filed 9–11–14; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2011–0224] Applications of Bioassay for Radioiodine Nuclear Regulatory Commission. ACTION: Regulatory guide; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing Revision 2 to Regulatory Guide (RG) 8.20, ‘‘Applications of Bioassay for Iodine125 and Iodine-131.’’ The title of this regulatory guide has been changed to ‘‘Applications of Bioassay for Radioiodine.’’ It describes methods and criteria acceptable to the NRC staff for the development and implementation of a bioassay program by licensees handling or processing unsealed materials containing Iodine-123 (I–123), Iodine-124 (I–124), Iodine-125 (I–125), Iodine-129 (I–129), and Iodine-131 (I– 131), or a combination of these radionuclides. SUMMARY: Please refer to Docket ID NRC–2011–0224 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this action by the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2011–0224. Address questions about NRC dockets to Carol Gallagher; telephone: 301–287–3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at tkelley on DSK3SPTVN1PROD with NOTICES ADDRESSES: VerDate Mar<15>2010 17:58 Sep 11, 2014 Jkt 232001 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. Revision 2 of RG 8.20 is available in ADAMS under Accession No. ML14064A060. The regulatory analysis may be found in ADAMS under Accession Number ML14064A058. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. FOR FURTHER INFORMATION CONTACT: Casper Sun, telephone: 301–251–7912, email: casper.sun@nrc.gov; or Harriet Karagiannis, telephone: 301–251–7477, email: harriet.karagiannis@nrc.gov. Both are staff of the Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. SUPPLEMENTARY INFORMATION: I. Introduction The NRC is issuing a revision to an existing guide in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public information methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. Revision 2 of RG 8.20 was issued with a temporary identification as draft regulatory guide (DG), DG–8050, entitled, ‘‘Applications for Bioassay for Radioiodine.’’ This guide was revised to achieve better alignment with: (1) Part 20 of Title 10 of the Code of Federal Regulations (10 CFR); and (2) the internal dose assessment methods recommended by the International Commission on Radiological Protection Publication 30, ‘‘Limits for Intakes of Radionuclides by Workers.’’ The content of the guide was also simplified by removing the appendixes of the previous version and including pertinent information in the main sections of the guide. Also, the title was changed because the guide now includes three more radioiodines (I–123, I–124, and I–129), in addition to the two PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 radioiodines (I–125 and I–131) that were included in the previous version. II. Additional Information This DG–8050 was published in the Federal Register on September 26, 2011, (76 FRN 59448) for a 60-day public comment period. The public comment period closed on November 22, 2011. Public comments on DG–8050 and the NRC staff’s responses to the public comments are available in ADAMS under Accession No. ML14064A061. III. Congressional Review Act This RG is a rule as defined in the Congressional Review Act (5 U.S.C. 801–808). However, the Office of Management and Budget has not found it to be a major rule as defined in the Congressional Review Act. IV. Backfitting and Issue Finality This RG describes methods that the staff of the NRC considers acceptable for the development and implementation of bioassay programs for adult workers and for licensees handling or processing unsealed materials containing I–123, I–124, I–125, I–129, and I–131 or a combination of these radionuclides. Some of the applicants and licensees to whom this regulatory guide applies are protected by backfitting provisions in certain parts of 10 CFR Chapter I and/ or the issue finality provisions in 10 CFR part 52. Issuance of this RG does not constitute backfitting under 10 CFR 50.109, 10 CFR 70.76, 10 CFR 72.62, or 10 CFR 76.76, and is not inconsistent with any issue finality provisions in 10 CFR part 52. As discussed in the ‘‘Implementation’’ section of this regulatory guide, the NRC has no current intention to impose this regulatory guide on any licensees, including holders of licenses protected by the backfitting and issue finality provisions listed above. Applicants for the licenses listed above are not protected by any backfitting and issue finality provisions. Backfitting and the issue finality provisions—with certain exclusions discussed below—are not intended to apply to every NRC action which substantially changes the expectations of current and future applicants. The exceptions to the general principle are applicable whenever an applicant references a part E:\FR\FM\12SEN1.SGM 12SEN1 Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices 52 license (e.g., an early site permit) and/or NRC’s regulatory approval (e.g., a design certification rule) with specified issue finality provisions. The staff does not, at this time, intend to impose the positions represented in this RG in a manner that is inconsistent with any part 52 issue finality provisions. If, in the future, the staff seeks to impose a position in the regulatory guide section in a manner which does not provide issue finality as described in the applicable issue finality provision, then the staff must address the criteria for avoiding issue finality in that issue finality provision. Dated at Rockville, Maryland, this 8th day of September, 2014. For the Nuclear Regulatory Commission. Thomas H. Boyce Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2014–21757 Filed 9–11–14; 8:45 am] Week of September 22, 2014—Tentative There are no meetings scheduled for the week of September 22, 2014. Week of September 29, 2014—Tentative Dated: September 9, 2014. Andrew Bates, Senior Advisor, Office of the Secretary. Week of October 6, 2014—Tentative OFFICE OF PERSONNEL MANAGEMENT Tuesday, October 7, 2014 9:00 a.m. Briefing on the Status of Near-Term Task Force Recommendation 2.1 for Seismic Hazard Reevaluations (Public Meeting) (Contact: Nicholas DiFrancesco, 301–415–1115) This meeting will be webcast live at the Web address—https://www.nrc.gov/. Week of October 13, 2014—Tentative NUCLEAR REGULATORY COMMISSION Wednesday, October 15, 2014 11:00 a.m. Discussion of Management and Personnel Issues (Closed—Ex. 2 and 6) Week of October 20, 2014—Tentative Sunshine Act Meeting Weeks of September 15, 22, 29, October 6, 13, 20, 2014. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and Closed. DATES: Week of September 15, 2014 Monday, September 15, 2014 1:30 p.m. NRC All Employees Meeting (Public Meeting), Marriott Bethesda North Hotel, 5701 Marinelli Road, Rockville, MD 20852 Tuesday, September 16, 2014 9:50 a.m. Affirmation Session (Public Meeting) (Tentative) Final Rule: Economic Simplified Boiling Water Reactor Design Certification (Tentative) This meeting will be webcast live at the Web address—https://www.nrc.gov/. 10:00 a.m. Briefing on Project Aim 2020 (Closed—Ex. 2) tkelley on DSK3SPTVN1PROD with NOTICES Thursday, September 18, 2014 9:00 a.m. Briefing on Management of Low-Level Waste, High-Level Waste, and Spent Nuclear Fuel (Public Meeting) (Contact: Cinthya ´ I. Roman, 301–287–9091) This meeting will be webcast live at the Web address—https://www.nrc.gov/. VerDate Mar<15>2010 17:58 Sep 11, 2014 Jkt 232001 distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969), or send an email to Patricia.Jimenez@nrc.gov or Brenda.Akstulewicz@nrc.gov. Thursday, October 2, 2014 10:00 a.m. Meeting with the Advisory Committee on Reactor Safeguards (ACRS) (Public Meeting) (Contact: Ed Hackett, 301–415–7360) This meeting will be webcast live at the Web address—https://www.nrc.gov/. BILLING CODE 7590–01–P [NRC–2014–0001] 54753 There are no meetings scheduled for the week of October 20, 2014. * * * * * The schedule for Commission meetings is subject to change on short notice. For more information or to verify the status of meetings, contact Rochelle Bavol at (301) 415–1651 or via email at Rochelle.Bavol@nrc.gov. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g. braille, large print), please notify Kimberly Meyer, NRC Disability Program Manager, at 301–287–0727, by videophone at 240–428–3217, or by email at Kimberly.Meyer-Chambers@ nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * Members of the public may request to receive this information electronically. If you would like to be added to the PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 [FR Doc. 2014–21933 Filed 9–10–14; 4:15 pm] BILLING CODE 7590–01–P Submission for Review: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery U.S. Office of Personnel Management. ACTION: 60-day notice and request for comments. AGENCY: The Office of Chief Information Officer, Office of Personnel Management (OPM) offers the general public and other Federal agencies the opportunity to comment on an information collection request (ICR) 3206–0257, ‘‘Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery.’’ As required by the Paperwork Reduction Act of 1995, (Pub. L. 104–13, 44 U.S.C. chapter 35) as amended by the Clinger-Cohen Act (Pub. L. 104–106), OPM is soliciting comments for this collection. DATES: Comments are encouraged and will be accepted until November 12, 2014. This process is conducted in accordance with 5 CFR 1320.1. ADDRESSES: Interested persons are invited to submit written comments on the proposed information collection to the Office of the Chief Information Officer, Records Management and Data Policy, Office of Personnel Management, 1900 E. Street NW., Washington, DC 20415, Attention: Paperwork Reduction Act Officer or sent by email to PRA@ opm.gov. SUMMARY: A copy of this ICR, with applicable supporting documentation, may be obtained by contacting the Office of the Chief Information Officer, Records Management and Data Policy, Office of Personnel Management, 1900 E. Street NW., Washington, DC 20503, Attention: Paperwork Reduction Act Officer or sent by email to PRA@opm.gov. SUPPLEMENTARY INFORMATION: The proposed information collection activity provides a means to garner qualitative customer and stakeholder feedback in FOR FURTHER INFORMATION CONTACT: E:\FR\FM\12SEN1.SGM 12SEN1

Agencies

[Federal Register Volume 79, Number 177 (Friday, September 12, 2014)]
[Notices]
[Pages 54752-54753]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21757]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2011-0224]


Applications of Bioassay for Radioiodine

AGENCY: Nuclear Regulatory Commission.

ACTION: Regulatory guide; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing 
Revision 2 to Regulatory Guide (RG) 8.20, ``Applications of Bioassay 
for Iodine-125 and Iodine-131.'' The title of this regulatory guide has 
been changed to ``Applications of Bioassay for Radioiodine.'' It 
describes methods and criteria acceptable to the NRC staff for the 
development and implementation of a bioassay program by licensees 
handling or processing unsealed materials containing Iodine-123 (I-
123), Iodine-124 (I-124), Iodine-125 (I-125), Iodine-129 (I-129), and 
Iodine-131 (I-131), or a combination of these radionuclides.

ADDRESSES: Please refer to Docket ID NRC-2011-0224 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this action by the 
following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2011-0224. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the NRC 
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. Revision 2 of RG 8.20 is 
available in ADAMS under Accession No. ML14064A060. The regulatory 
analysis may be found in ADAMS under Accession Number ML14064A058.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
    Regulatory guides are not copyrighted, and NRC approval is not 
required to reproduce them.

FOR FURTHER INFORMATION CONTACT: Casper Sun, telephone: 301-251-7912, 
email: casper.sun@nrc.gov; or Harriet Karagiannis, telephone: 301-251-
7477, email: harriet.karagiannis@nrc.gov. Both are staff of the Office 
of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001.

SUPPLEMENTARY INFORMATION: 

I. Introduction

    The NRC is issuing a revision to an existing guide in the NRC's 
``Regulatory Guide'' series. This series was developed to describe and 
make available to the public information methods that are acceptable to 
the NRC staff for implementing specific parts of the agency's 
regulations, techniques that the staff uses in evaluating specific 
problems or postulated accidents, and data that the staff needs in its 
review of applications for permits and licenses.
    Revision 2 of RG 8.20 was issued with a temporary identification as 
draft regulatory guide (DG), DG-8050, entitled, ``Applications for 
Bioassay for Radioiodine.'' This guide was revised to achieve better 
alignment with: (1) Part 20 of Title 10 of the Code of Federal 
Regulations (10 CFR); and (2) the internal dose assessment methods 
recommended by the International Commission on Radiological Protection 
Publication 30, ``Limits for Intakes of Radionuclides by Workers.'' The 
content of the guide was also simplified by removing the appendixes of 
the previous version and including pertinent information in the main 
sections of the guide. Also, the title was changed because the guide 
now includes three more radioiodines (I-123, I-124, and I-129), in 
addition to the two radioiodines (I-125 and I-131) that were included 
in the previous version.

II. Additional Information

    This DG-8050 was published in the Federal Register on September 26, 
2011, (76 FRN 59448) for a 60-day public comment period. The public 
comment period closed on November 22, 2011. Public comments on DG-8050 
and the NRC staff's responses to the public comments are available in 
ADAMS under Accession No. ML14064A061.

III. Congressional Review Act

    This RG is a rule as defined in the Congressional Review Act (5 
U.S.C. 801-808). However, the Office of Management and Budget has not 
found it to be a major rule as defined in the Congressional Review Act.

IV. Backfitting and Issue Finality

    This RG describes methods that the staff of the NRC considers 
acceptable for the development and implementation of bioassay programs 
for adult workers and for licensees handling or processing unsealed 
materials containing I-123, I-124, I-125, I-129, and I-131 or a 
combination of these radionuclides. Some of the applicants and 
licensees to whom this regulatory guide applies are protected by 
backfitting provisions in certain parts of 10 CFR Chapter I and/or the 
issue finality provisions in 10 CFR part 52.
    Issuance of this RG does not constitute backfitting under 10 CFR 
50.109, 10 CFR 70.76, 10 CFR 72.62, or 10 CFR 76.76, and is not 
inconsistent with any issue finality provisions in 10 CFR part 52. As 
discussed in the ``Implementation'' section of this regulatory guide, 
the NRC has no current intention to impose this regulatory guide on any 
licensees, including holders of licenses protected by the backfitting 
and issue finality provisions listed above. Applicants for the licenses 
listed above are not protected by any backfitting and issue finality 
provisions. Backfitting and the issue finality provisions--with certain 
exclusions discussed below--are not intended to apply to every NRC 
action which substantially changes the expectations of current and 
future applicants. The exceptions to the general principle are 
applicable whenever an applicant references a part

[[Page 54753]]

52 license (e.g., an early site permit) and/or NRC's regulatory 
approval (e.g., a design certification rule) with specified issue 
finality provisions. The staff does not, at this time, intend to impose 
the positions represented in this RG in a manner that is inconsistent 
with any part 52 issue finality provisions. If, in the future, the 
staff seeks to impose a position in the regulatory guide section in a 
manner which does not provide issue finality as described in the 
applicable issue finality provision, then the staff must address the 
criteria for avoiding issue finality in that issue finality provision.

    Dated at Rockville, Maryland, this 8th day of September, 2014.

    For the Nuclear Regulatory Commission.
Thomas H. Boyce
Chief, Regulatory Guidance and Generic Issues Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2014-21757 Filed 9-11-14; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.